Oxygenta Pharmaceutical Ltd - Board Meeting Outcome for Audited Financial Results For The Year Ended 31St March 2023

Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") read with Schedule III to the said Regulations, this is to inform you that the Board of Directors of the Company, at their meeting held on Thursday, 30th May, 2024, inter alia, transacted the following items of business: 1. Considered and approved the Audited Financial Results for the fourth quarter and Financial Year Ended 31st March, 2024. The said Audited Financial Results were reviewed by the Audit Committee and thereafter approved by the Board of Directors. 2. Appointment of M/s. S Siva Parvathi & Associates, Chartered Accountants, (Firm Registration No.020872S), as the Internal Auditors of the Company for the financial year 2024-25.